Back to dashboard
MedicaidCoverageMedium impact

Newsletter Vol. 20, No.24

New Jersey Medicaid·NJ · Oncology, Hematology·Medical Policy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

This policy update addresses changes to General Assistance (GA) coverage for two chemotherapy drugs: Alimta® (pemetrexed) and Gemzar® (gemcitabine). The changes likely affect coverage criteria, prior authorization requirements, or reimbursement for these oncology medications.

Action Required

Action needed
Immediately: Download and review the full policy document from the provided URL to understand specific coverage changes for Alimta® and Gemzar®. Oncology billing team should verify current prior authorization requirements and coverage criteria for these medications. Update billing protocols and inform providers of any new documentation requirements.

Related policy hubs